Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 2021

View Archived Issues

Kyoto University develops sequence-selective mitochondrial DNA alkylators for mitochondrial diseases

Pelareorep shows synergistic effect with radiotherapy in basal-like breast cancer

Dual SYK/VEGFR2 inhibitors discovered at Ocumension Therapeutics

Sichuan Kelun-Biotech Biopharmaceutical presents new PPAR receptor agonists

Fochon Pharmaceuticals describes CDK2/CDK4/CDK6 inhibitors

New necroptosis inhibitors synthesized at Anaxis Pharma

DIO2 as a new promising prognostic biomarker for patients with early-stage NSCLC

Identification of genomic correlates of clinical outcomes in metastatic uveal melanoma

IL2RA is a prognostic immune marker in epithelial ovarian cancer

STING agonists show preclinical promise for glioblastoma and pancreatic cancer therapy

New osteoarthritis risk variants and drug targets identified in large GWAS meta-analysis

Discovery of novel BRAF dimer inhibitors with promising efficacy

Seneca launches cancer gene delivery platform based on SVV-001 technology

Clearmind and Hebrew University partner on novel psychedelics

CMTA and Addex collaborate to investigate GABA-B PAMs for CMT1A

Theragnostics and AAA to jointly develop Ga-68 one-step PET radiopharmaceuticals

SNP in the CBS gene tied to overall survival in patients with NSCLC

Novel OSBPL7-targeting compounds show therapeutic efficacy in models of renal disease

Mosaic licenses rights to novel vaccine candidates from UC San Diego

Synthetic queuine STL-101 shows neuroprotective potential

Inhaled antibodies brought to SARS-CoV fight

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...